Skip to search formSkip to main contentSkip to account menu

Temodal

National Institutes of Health

Related topics

Related topics

2 relations
Temodartemozolomide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
The combi-targeting concept: mechanism of action of the pleiotropic combi-molecule RB24 and discovery of a novel cell signaling-based combination principle.
2010
2010
Postoperative chemo-radiotherapy with temodal in patients with glioblastoma multiforme--survival rates and prognostic factors.
UNLABELLED Glioblastoma multiforme (GM) is the most malignant histological type of brain tumors. It affects the active age and… 
2009
2009
[Diagnostic and treatment delays do not modify the treatment outcome of patients with multiform glioblastoma].
2008
2008
Ark floats gene therapy's boat, for now
2008
2008
Combi-targeting concept: an optimized single-molecule dual-targeting model for the treatment of chronic myelogenous leukemia
Blockade of Bcr-Abl by the inhibitor Imatinib has proven efficacious in the therapy of chronic myelogenous leukemia (CML… 
2007
2007
Metronomic chemotherapy dosing-schedules with estramustine and temozolomide act synergistically with anti-VEGFR-2 antibody to cause inhibition of human umbilical venous endothelial cell growth
The effects of ‘metronomic'or extended chemotherapy dosing schedules (ECS) are mediated through poorly understood anti-angiogenic… 
Review
2003
Review
2003
Benefits of adjuvant chemotherapy in high-grade gliomas.
The current standard of care for patients with high-grade glioma is resection followed by radiotherapy. Adjuvant chemotherapy is… 
Review
2003
Review
2003
The treatment of elderly patients with high-grade gliomas.
Elderly patients with cancer are frequently excluded from cancer therapy trials, treated suboptimally, or not treated at all… 
Review
2002
Review
2002
The use of temozolomide in recurrent malignant gliomas.
Gliomas are the most common primary intracerebral tumours and over 60% of these are malignant. Standard treatment in the UK for… 
1998
1998
Phase II study of Temodal in the treatment of patients with advanced nasopharyngeal carcinoma
Purpose: A single-institution phase II trial of Temodal (temozolomide, SCH52365) in Chinese patients with advance nasopharyngeal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)